Core Competences

The Phase I Unit is designed to conduct trials for:

• First-in-Man Administration (SAD and MAD)
• Imaging Studies including microdosing using PET, PET/CT, fMRI
• Proof of Concept Studies (microdosing, phase Ib)
• Special Patient Populations
  

  – Diabetes type I and II
  

  – Obese
  

  – CNS (Alzheimer Disease, Parkinson Disease and Multiple Sclerosis)

  – Elderly
  
• Other
  

  – PD/PK
  

  – Food Interaction
  

  – Bioequivalence/Bioavailability
  

  – Catheterization/ Biopsies
  

  – CLAMP

  – Pharmacokinetic profile

  – PK/PD modelling

Recent Experience Phase 1 studies >>>

Contact us to get more information on our past experience in early clinical trials.